Zhuhai Rundu Pharmaceutical Co Ltd Class A Asset Resilience Ratio

Latest as of June 2026: 0.00%

Zhuhai Rundu Pharmaceutical Co Ltd Class A asset resilience ratio. Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has an Asset Resilience Ratio of 0.00% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥33.70K
≈ $4.93K USD Cash + Short-term Investments

Total Assets

CN¥2.02 Billion
≈ $296.30 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Zhuhai Rundu Pharmaceutical Co Ltd Class A (2020–2025)

Asset resilience ratio of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2020 to 2025. This chart shows how Zhuhai Rundu Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. Read Zhuhai Rundu Pharmaceutical Co Ltd Class debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Zhuhai Rundu Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Zhuhai Rundu Pharmaceutical Co Ltd Class's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥33.70K 0.0%
Total Liquid Assets CN¥33.70K 0.00%

Asset Resilience Insights

  • Limited Liquidity: Zhuhai Rundu Pharmaceutical Co Ltd Class A maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhuhai Rundu Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio

Compare Zhuhai Rundu Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Sandoz Group AG
SW:SDZ
Drug Manufacturers - Specialty & Generic 7.89%
H Lundbeck A/S
CO:HLUN-B
Drug Manufacturers - Specialty & Generic -0.56%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 47.16%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Viyash Scientific Limited
NSE:SEQUENT
Drug Manufacturers - Specialty & Generic 0.08%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%

Zhuhai Rundu Pharmaceutical Co Ltd Class A Asset Resilience Ratio by Year (2020–2025)

Zhuhai Rundu Pharmaceutical Co Ltd Class A asset resilience ratio by year from 2020 to 2025. The table below shows the annual Asset Resilience Ratio data for Zhuhai Rundu Pharmaceutical Co Ltd Class A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.00% CN¥53.63K
≈ $7.85K
CN¥2.03 Billion
≈ $296.85 Million
0.00pp
2024-12-31 0.00% CN¥65.71K
≈ $9.62K
CN¥2.19 Billion
≈ $321.00 Million
+0.00pp
2023-12-31 0.00% CN¥52.23K
≈ $7.64K
CN¥2.23 Billion
≈ $325.99 Million
0.00pp
2022-12-31 0.00% CN¥61.78K
≈ $9.04K
CN¥2.29 Billion
≈ $334.56 Million
0.00pp
2021-12-31 0.00% CN¥86.77K
≈ $12.70K
CN¥1.91 Billion
≈ $279.41 Million
-2.90pp
2020-12-31 2.91% CN¥44.01 Million
≈ $6.44 Million
CN¥1.51 Billion
≈ $221.51 Million
--
pp = percentage points

About Zhuhai Rundu Pharmaceutical Co Ltd Class A

SHE:002923 China Drug Manufacturers - Specialty & Generic
Market Cap
$450.85 Million
CN¥3.08 Billion CNY
Market Cap Rank
#12506 Global
#3620 in China
Share Price
CN¥9.20
Change (1 day)
+1.10%
52-Week Range
CN¥8.81 - CN¥17.35
All Time High
CN¥20.52
About

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular, gastrointestinal, antibiotics, analgetic and antipyretics, anti-virus, endocrinology, and respiratory; and pellets for excipient, antiulcerative, diabetes … Read more